Buy & Sell Hetzer Medical Indonesia Tbk. - MEDS Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp6.63B | +3.73% |
| Cost of Revenue | Rp6.03B | +8.81% |
| Gross Profit | Rp600.43M | -29.41% |
| General Expenses, Depreciation, Interest | Rp8.87B | -6.86% |
| Operating Profit | -Rp8.27B | -4.65% |
| Other Income | -Rp297.46M | -174.37% |
| EBT | -Rp8.57B | +3.56% |
| Taxes | Rp221.9M | -185.36% |
| Net Income | -Rp8.35B | -2.2% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp61.77B | -5.41% |
| Total Liabilities | Rp13.47B | +55.05% |
| Total Equity | Rp48.3B | -14.69% |
| Total Liabilities & Total Equity | Rp61.77B | -5.41% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp1.48B | -166.15% |
| CF from Investment | Rp1.11B | -407.94% |
| CF from Financing | Rp3.13B | -203.62% |
| Net Cash Flow | Rp546.94M | -226.17% |